# INSPIRIS RESILIA Aortic Valve, Valve-in-Valve Surveillance Study

> **NCT04902053** · — · SUSPENDED · sponsor: **Edwards Lifesciences** · enrollment: 50 (estimated)

## Conditions studied

- Aortic Valve Replacement

## Interventions

- **DIAGNOSTIC_TEST:** Subjects previously implanted with INSPIRIS RESILIA Model 11500A and are undergoing planned valve-in-valve treatment.

## Key facts

- **NCT ID:** NCT04902053
- **Lead sponsor:** Edwards Lifesciences
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** SUSPENDED
- **Start date:** 2028-06
- **Primary completion:** 2030-12
- **Final completion:** 2031-01
- **Target enrollment:** 50 (ESTIMATED)
- **Why stopped:** Lack of enrollment. Study will be restarted when there is sufficient INSPIRIS Valve in Valve case volume to support enrollment.
- **Last updated:** 2025-09-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04902053

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04902053, "INSPIRIS RESILIA Aortic Valve, Valve-in-Valve Surveillance Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04902053. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*